These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21556455)

  • 1. Affordable hypertension therapy for diabetic patients.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(2):98. PubMed ID: 21556455
    [No Abstract]   [Full Text] [Related]  

  • 2. Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients.
    Usui I; Fujisaka S; Yamazaki K; Takano A; Murakami S; Yamazaki Y; Urakaze M; Hachiya H; Takata M; Senda S; Iwata M; Satoh A; Sasaoka T; Ak ND; Temaru R; Kobayashi M
    Diabetes Res Clin Pract; 2007 Aug; 77(2):210-4. PubMed ID: 17240472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan: just an antihypertensive agent? A literature review.
    Destro M; Cagnoni F; Dognini GP; Galimberti V; Taietti C; Cavalleri C; Galli E
    Expert Opin Pharmacother; 2011 Dec; 12(17):2719-35. PubMed ID: 22077832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and effective treatment of hypertension: ONTARGET provides some answers.
    Cardiovasc J Afr; 2009; 20(5):323. PubMed ID: 19907811
    [No Abstract]   [Full Text] [Related]  

  • 5. A third amlodipine/ARB combination (Twynsta) for hypertension.
    Med Lett Drugs Ther; 2010 Jan; 52(1329):2-3. PubMed ID: 20208469
    [No Abstract]   [Full Text] [Related]  

  • 6. A physician with pounding headaches.
    Licitra R; Basso V; Pannarale G
    Blood Press Monit; 2008 Apr; 13(2):131-2. PubMed ID: 18347449
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lowering blood pressure substantially--and the diabetes risk as well?].
    MMW Fortschr Med; 2006 Jul; 148(29-30):48-9. PubMed ID: 16910410
    [No Abstract]   [Full Text] [Related]  

  • 8. ARBs for cardiovascular and renal protection in high-risk patients.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):224. PubMed ID: 21881697
    [No Abstract]   [Full Text] [Related]  

  • 9. [Normal blood pressure values in general practice are not enough. Also measure "morning after" values].
    MMW Fortschr Med; 2004 May; 146(19):62. PubMed ID: 15357487
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of hypertension in the progression of diabetic microangiopathy].
    Kamide K; Rakugi H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():98-102. PubMed ID: 15999692
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progress on the drug therapy for diabetic microangiopathies: RA system inhibitor].
    Higashiura K; Shimamoto K
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():144-9. PubMed ID: 15999698
    [No Abstract]   [Full Text] [Related]  

  • 12. Need for new hypertension guidelines for high-risk patients.
    Cardiovasc J Afr; 2009; 20(4):267. PubMed ID: 19701544
    [No Abstract]   [Full Text] [Related]  

  • 13. [Assessment of antihypertensive effect of telmizartan in patients with hypertensive disease].
    Skavronskaia TV; Fedoseeva LA; Leus AI; Preobrazhenskiĭ DV
    Kardiologiia; 2005; 45(2):56. PubMed ID: 15798709
    [No Abstract]   [Full Text] [Related]  

  • 14. [Despite drug treatment, ever second hypertensive patient with morning blood pressure too high].
    MMW Fortschr Med; 2004 Aug; 146(33-34):52. PubMed ID: 15526635
    [No Abstract]   [Full Text] [Related]  

  • 15. [In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension].
    MMW Fortschr Med; 2006 Jun; 148(26):50-1. PubMed ID: 16875381
    [No Abstract]   [Full Text] [Related]  

  • 16. Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activity.
    Toyama K; Nakamura T; Kataoka K; Yasuda O; Fukuda M; Tokutomi Y; Dong YF; Ogawa H; Kim-Mitsuyama S
    Biochem Biophys Res Commun; 2011 Jul; 410(3):508-13. PubMed ID: 21679694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
    Serebruany VL; Atar D; Hanley DF
    Cerebrovasc Dis; 2008; 26(5):563-4. PubMed ID: 18936537
    [No Abstract]   [Full Text] [Related]  

  • 18. Mild-to-moderate uncomplicated hypertension: further analysis of a cost-effectiveness study of five drugs.
    Richter A; Gondek K; Ostrowski C; Dombeck M; Lamb S
    Manag Care Interface; 2001 Jul; 14(7):61-9. PubMed ID: 11481819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the PPAR-γ-activating property of telmisartan provide a benefit in clinical practice?
    Fujimura A; Ushijima K; Ando H
    Hypertens Res; 2013 Feb; 36(2):183. PubMed ID: 23190691
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of hypertension. Also pulse pressure must be reduced].
    MMW Fortschr Med; 2003 Sep; 145(37):65. PubMed ID: 14584451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.